Immigration and Healthcare: No Talking Points This Election

Immigrants on a steamship heading around the Statue of Liberty. Credit: Library of Congress

This week, I will be attending a two-day meeting on immigration and healthcare.  It’s not an area that I know a lot about and I am interested in your thoughts on the topic. Presidential candidates are not discussing the issues.

One worry that I have concerns privatizing of many public healthcare programs that have served immigrants well for centuries. America seems keen on privatizing right now, but the benefits and harms are not clearly known.

These issues are on my mind:

  1. Will immigrants who were able to get care in the public sector still have the same access once health care is privatized?
  2. Will preventive care, chronic care be available?
  3. Will more care be provided in the emergency room?
  4. Will shrinkage of the public sector mean that they will be sicker?
  5. What will happen to elderly immigrants? Will the healthcare system accommodate immigrants when they decline?
  6. What can be done in health policy and planning to bolster equity and fairness?

What are your thoughts on this issue?


An Argument for Lowering Thyroid Medication, Closer Thyroid Monitoring After Menopause

This study found a twofold to threefold increased risk of fracture in people over age 70 on higher doses of thyroid replacement, especially over 0.093 mg per day. In the past, high thyroid replacement doses have been shown to be related to lower bone density and other risk factors for falls and fractures.

Bone fractures are rough on older people, and that’s why a study showing excess doses of thyroid hormone replacement are related to bone fractures should give you and your doctor pause. Closer monitoring of your thyroid dose and a reassessment of the dose that worked well for you for years should be considered.

Doctors are learning that after menopause, your body does not need as much thyroxine (the main hormone in the thyroid gland), which bolsters your metabolic rate and growth.

In a large population-based retrospective study of nearly ¼ million Canadians over age 70 using thyroid replacement therapy, aka levothyroxine (88 percent were women) thyroid replacement therapy in Ontario, Canada, Lorraine Lipscombe, MD, assistant professor of medicine at endocrinology at Women’s College Hospital, Toronto, and coauthors looked at the effect of thyroid replacement dose on fractures of the wrist, forearm, shoulder, spine, pelvis, hip or femur, or lower leg or ankle.

As the study authors point out, hypothyroidism is usually diagnosed in early or middle adulthood and older people taking thyroid replacement therapy have been taking it for decades when they reach older age. Furthermore, people are often on the same dose for years. If a woman requires less thyroid replacement, but is overtreated, she may develop iatrogenic hyperthyroidism, meaning that the hyperthyroidism was caused by excess dosing.

The study also begs the question as to whether reference ranges for “normal” TSH levels are appropriate for older people and groups other than Caucasians. Thus far, studies in these populations has been limited. Funding such studies should be a top priority for health care researchers.

The study, published in the BMJ, is important because prescription of thyroid replacementtherapy is widespread; millions of people take thyroid replacement therapy for hypothyroidism in generic and brand formulations. They are top drugs purchased in the US. The study follows others showing increases in fracture. Overdosing of thyroid replacement therapy has also been associated with heart risks, such as atrial fibrillation.

As people ponder whether healthcare reform can help or harm in the United States, it is worth underscoring that healthcare research on large unified population database studies like those in Canada is much easier to perform because the entire population is covered under a single payer. Research is also far cheaper administratively.